6678.T JPX
Techno Medica Co., Ltd.
1W: -2.2%
1M: -2.2%
3M: +1.6%
YTD: -19.4%
1Y: +2.7%
3Y: +0.8%
5Y: +44.4%
¥2,000.00 ($12.67)
-24.00 (-1.19%)
Weekly Expected Move ±1.9%
¥1922
¥1961
¥2000
¥2039
¥2078
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$978M
-14.5% ▼
5Y CAGR: -5.1%
Capital Expenditures
$25M
+75.7% ▲
5Y CAGR: -43.3%
Free Cash Flow
$953M
-8.4% ▼
5Y CAGR: +2.5%
Dividends Paid
$470M
+7.5% ▲
Buybacks
$0
+100.0% ▲
Net Change in Cash
$475M
+115.0% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $1.6B | $1.9B | $1.7B | $1.3B | $1.0B |
| Depreciation & Amort. | $121M | $121M | $108M | $113M | $100M |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$684M | $721M | -$245M | -$346M | $133M |
| Other Non-Cash Items | -$261M | -$630M | -$642M | $27M | -$259M |
| Operating Cash Flow | $825M | $2.1B | $887M | $1.1B | $978M |
| — Investing Activities — | |||||
| Capital Expenditures | -$34M | -$80M | -$139M | -$102M | -$32M |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | -$120M | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $2.6B | $0 | $0 | $0 |
| Other Investing | $388K | $719K | -$17M | $2M | -$777K |
| Investing Cash Flow | -$154M | $2.5B | -$155M | -$101M | -$32M |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $0 | $0 | $0 |
| Stock Repurchased | $0 | -$164M | $0 | -$3.7B | $0 |
| Dividends Paid | -$415M | -$434M | -$505M | -$508M | -$470M |
| Other Financing | $0 | $0 | $0 | -$1K | $0 |
| Financing Cash Flow | -$415M | -$599M | -$505M | -$4.2B | -$470M |
| Net Change in Cash | $256M | $4.0B | $227M | -$3.2B | $475M |
| Cash End of Period | $7.6B | $11.5B | $11.8B | $8.6B | $9.1B |
| Free Cash Flow | $792M | $2.0B | $749M | $1.0B | $953M |